Mitsubishi Tanabe Pharma America, Inc. will conduct a study to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).....
Ampersand Capital Partners?has completed the acquisition of?Pacific Biomarkers?and merged it with existing portfolio company?Neomed-Labs. This merger brings together two bioanalytical